4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
Key Takeaways
- Task B5 requires monitoring intra-procedural lab values and names ACT, glucose, and arterial blood gas explicitly.
- Normal serum potassium is 3.5-5.0 mEq/L; values below 3.5 promote early afterdepolarizations and torsades, and values above 6.0 widen the QRS and can render tissue inexcitable.
- Baseline ACT is 70-180 seconds; left atrial work targets 300-350 seconds, and arterial sheaths are pulled below roughly 150-180 seconds.
- Serum magnesium below 1.7 mg/dL frequently coexists with hypokalemia and must be corrected first, because potassium repletion fails while magnesium is low.
- End-tidal CO2 rising above 50 mmHg with a falling respiratory rate signals sedation-induced hypoventilation before pulse oximetry desaturates.
4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
CCI separates "Monitor patient vital signs" (B2) from "Monitor intra-procedural labs values (e.g., ACT, glucose, ABG)" (B5), and the knowledge list independently names normal vital signs and normal lab values. These are recall items: the exam presents a number and expects instant classification as normal, actionable, or dangerous.
1. Normal Adult Vital Signs
| Parameter | Normal adult range |
|---|---|
| Heart rate | 60-100 bpm |
| Respiratory rate | 12-20 breaths/min |
| Blood pressure | Systolic < 120 and diastolic < 80 mmHg (normal); hypotension generally systolic < 90 |
| Mean arterial pressure (MAP) | 70-100 mmHg; ≥ 65 mmHg needed for organ perfusion |
| Temperature | 36.5-37.5 °C (97.7-99.5 °F) |
| SpO₂ | 95-100% on room air |
| End-tidal CO₂ (EtCO₂) | 35-45 mmHg |
MAP calculation:
For a blood pressure of 96/54: MAP = (96 + 108) / 3 = 68 mmHg — at the edge of adequate perfusion and worth announcing.
Pulse pressure (SBP − DBP) narrows in tamponade and hypovolemia and widens in aortic regurgitation. Pulsus paradoxus, an inspiratory systolic fall greater than 10 mmHg, is a cardinal sign of tamponade and is one of the earliest changes a specialist watching an arterial line will see during a perforation.
2. Normal Laboratory Values
Electrolytes and renal function
| Analyte | Normal range | EP significance |
|---|---|---|
| Potassium (K⁺) | 3.5-5.0 mEq/L | The single most arrhythmogenic electrolyte |
| Magnesium (Mg²⁺) | 1.7-2.2 mg/dL | Cofactor for the Na⁺/K⁺ ATPase; must be corrected before potassium |
| Sodium (Na⁺) | 135-145 mEq/L | Severe derangement affects conduction |
| Calcium, ionized | 4.5-5.6 mg/dL (total 8.5-10.5) | Affects QT and contractility |
| BUN | 7-20 mg/dL | Contrast and drug dosing |
| Creatinine | 0.6-1.2 mg/dL | Renal clearance of sotalol, dofetilide, DOACs |
| Glucose | 70-100 mg/dL fasting | Sedation safety; GLP-1 and SGLT2 considerations |
Hematology and coagulation
| Analyte | Normal range | EP significance |
|---|---|---|
| Hemoglobin | 13.5-17.5 g/dL (men), 12.0-15.5 (women) | Bleeding risk, oxygen delivery |
| Hematocrit | 41-53% (men), 36-46% (women) | Serial drop signals occult bleeding |
| Platelets | 150,000-400,000/µL | Below 50,000 is a relative contraindication to large-bore access |
| INR | 0.8-1.1 untreated; 2.0-3.0 on therapeutic warfarin | Uninterrupted warfarin ablation strategy |
| aPTT | 25-35 s | Heparin monitoring outside the lab |
| ACT (baseline) | 70-180 s | Point-of-care intra-procedural anticoagulation |
Cardiac and endocrine
| Analyte | Normal / threshold | EP significance |
|---|---|---|
| Troponin | Assay-specific; elevated post-ablation is expected | Not interpreted as infarction after ablation |
| BNP / NT-proBNP | BNP < 100 pg/mL | Heart failure status before CRT |
| TSH | 0.4-4.0 mIU/L | Amiodarone-induced thyroid dysfunction |
| Digoxin level | 0.5-2.0 ng/mL (narrower in heart failure) | Toxicity causes DAD-mediated arrhythmia |
3. Electrolytes as Arrhythmia Mechanisms
Potassium. The exam expects the mechanism, not just the number.
| State | ECG changes | Arrhythmia mechanism |
|---|---|---|
| Hypokalemia (< 3.5) | ST depression, flattened T, prominent U wave, long QU | Prolonged repolarization → early afterdepolarizations → torsades |
| Hyperkalemia (> 5.5) | Peaked T waves → flattened P → widened QRS → sine wave | Resting membrane depolarization inactivates sodium channels → conduction slows, tissue becomes inexcitable, capture is lost |
Hyperkalemia is the classic cause of an acute rise in pacing threshold with loss of capture in a device patient; hypokalemia is the classic cause of peri-procedural torsades and of failure to maintain sinus rhythm after cardioversion.
Magnesium is a required cofactor for the Na⁺/K⁺ ATPase. While magnesium is low, the pump cannot retain potassium and repletion simply spills into the urine — which is why magnesium is corrected first, or at least concurrently. Intravenous magnesium is also the first-line treatment for torsades de pointes regardless of the serum level.
Calcium shortens the QT when high and lengthens it when low; severe hypocalcemia contributes to a long-QT substrate.
Practical thresholds before elective ablation: correct potassium to at least 4.0 mEq/L and magnesium to at least 2.0 mg/dL, because both improve arrhythmia stability during mapping and reduce the incidence of non-clinical induced arrhythmias.
4. Point-of-Care Testing at the Table
Activated clotting time
The ACT is a whole-blood, point-of-care measure of the intrinsic and common pathways, run on a bedside analyzer.
| Setting | Target ACT |
|---|---|
| Baseline, no heparin | 70-180 s |
| Right-sided diagnostic EP study | Often no heparin, or a low bolus |
| Left atrial work (transseptal, PVI, LA flutter) | 300-350 s |
| Retrograde aortic LV mapping | ≥ 250-300 s |
| Arterial sheath removal with manual compression | < 150-180 s |
Sampling technique matters and is testable: draw from an arterial line or a dedicated non-heparinized access, discard an adequate waste volume, and never draw through a heparinized sheath flush line — a contaminated sample returns a falsely prolonged ACT and leads to under-anticoagulation of the patient. The first ACT after the heparin bolus is checked at about 10-15 minutes and then every 20-30 minutes.
Factors that alter ACT independent of heparin dose: hypothermia and hemodilution prolong it; antithrombin III deficiency produces heparin resistance with a stubbornly low ACT despite escalating dosing; high platelet counts and aprotinin can shorten it. Patients on chronic heparin exposure often show relative resistance.
Glucose
Sedation masks hypoglycemia, whose adrenergic and neuroglycopenic signs — diaphoresis, tremor, confusion — are indistinguishable from sedation effects. Point-of-care glucose is checked in any diabetic patient, any patient held NPO longer than expected, and any patient with unexplained agitation or altered mental status. Treatment thresholds: below 70 mg/dL is hypoglycemia; below 54 mg/dL is clinically significant; treat intravenously with dextrose in a sedated patient who cannot swallow.
Two contemporary medication issues appear in current guidance: GLP-1 receptor agonists delay gastric emptying and raise aspiration risk under sedation, and SGLT2 inhibitors are held before procedures because of euglycemic diabetic ketoacidosis risk.
Arterial blood gas
| Value | Normal |
|---|---|
| pH | 7.35-7.45 |
| PaCO₂ | 35-45 mmHg |
| PaO₂ | 80-100 mmHg |
| HCO₃⁻ | 22-26 mEq/L |
| Base excess | −2 to +2 |
| SaO₂ | 95-100% |
The pattern that matters most in the EP lab is acute respiratory acidosis from sedation-induced hypoventilation: pH low, PaCO₂ high, bicarbonate normal because there has been no time for renal compensation. A metabolic acidosis with a rising lactate during a long case suggests hypoperfusion — occult bleeding, tamponade, or prolonged hypotension — and is an early warning that precedes overt hemodynamic collapse.
Capnography provides continuous, breath-by-breath ventilation monitoring and detects hypoventilation and apnea before pulse oximetry falls, particularly in a patient receiving supplemental oxygen whose SpO₂ can remain deceptively normal for minutes after ventilation stops. A rising EtCO₂ with a falling respiratory rate is the earliest actionable signal of over-sedation.
During a long ventricular tachycardia ablation, a patient with chronic kidney disease develops progressive loss of ventricular capture from the RV pacing catheter at outputs that captured reliably an hour earlier, and the QRS on the surface ECG has widened. Which laboratory abnormality best explains this?
A specialist draws an ACT sample through the side-arm flush line of a heparinized transseptal sheath and obtains a result of 480 seconds, while the previous peripheral sample fifteen minutes earlier was 310 seconds with no additional heparin given. What is the correct interpretation and action?
Thirty minutes into a case under moderate sedation with midazolam and fentanyl, capnography shows the respiratory rate falling from 14 to 7 breaths per minute with end-tidal CO2 rising from 38 to 54 mmHg, while pulse oximetry on 4 L nasal cannula remains 98 percent. What does this pattern indicate?